As early as Tuesday, the U.S. Court of Appeals
for the District of Columbia Circuit could issue a decision in that
case, which is well-known among Obamacare experts, but largely unheard
of by the general public.
Oral arguments heard by a three-judge panel on that court in March—when two of the judges appeared sympathetic to the plaintiffs—gave Halbig supporters renewed hope that their claim will prevail.
"This has been under the radar for so long," said Michael Cannon, director of health policy studies at the libertarian Cato Institute, one of the architects of the argument used in the Halbig case and in three other similar, pending federal court challenges to Obamacare. Halbig is expected to be the one decided at the appellate level first, although another one that was originally filed in Virginia federal court is also on the verge of being decided in the 4th U.S. Circuit Court of Appeals.
http://www.cnbc.com/id/101807858
Oral arguments heard by a three-judge panel on that court in March—when two of the judges appeared sympathetic to the plaintiffs—gave Halbig supporters renewed hope that their claim will prevail.
"This has been under the radar for so long," said Michael Cannon, director of health policy studies at the libertarian Cato Institute, one of the architects of the argument used in the Halbig case and in three other similar, pending federal court challenges to Obamacare. Halbig is expected to be the one decided at the appellate level first, although another one that was originally filed in Virginia federal court is also on the verge of being decided in the 4th U.S. Circuit Court of Appeals.
http://www.cnbc.com/id/101807858
